You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新諾威(300765.SZ):控股股東擬增持0.5億元-1.0億元公司股份 已增持55.32萬股
格隆匯 12-08 18:49

格隆匯12月8日丨新諾威(300765.SZ)公佈,公司於2023年12月8日收到控股股東石藥集團恩必普藥業有限公司(簡稱“恩必普藥業”)通知,其於2023年12月8日通過深圳證券交易所集中競價系統,增持公司股份55.32萬股,佔公司總股本的0.05%(已剔除最新披露的公司回購專用賬户中的股份數量計算,下同),增持金額為20,322,106.56元。

恩必普藥業擬自2023年12月8日(含本日)起6個月內,擇機增持公司股份,增持金額不低於人民幣5000.00萬元,不超過人民幣10000.00萬元(含首次增持股份金額2032.21萬元)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account